
### [MONDO:0019155](http://purl.obolibrary.org/obo/MONDO_0019155)
**Label:** leydig cell hypoplasia

**Subclasses:** [MONDO:0009384](http://purl.obolibrary.org/obo/MONDO_0009384) (leydig cell hypoplasia, type 1), 

**Corr. equiv. classes:** [Orphanet:96266](http://www.orpha.net/ORDO/Orphanet_96266), [Orphanet:96265](http://www.orpha.net/ORDO/Orphanet_96265), [Orphanet:755](http://www.orpha.net/ORDO/Orphanet_755), [OMIM:238320](http://purl.obolibrary.org/obo/OMIM_238320), 

**Class expressions from DL-Learner:**

- [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) and [HP:0100783](http://purl.obolibrary.org/obo/HP_0100783) (Breast aplasia) 62.50%
- [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) and [HP:0031066](http://purl.obolibrary.org/obo/HP_0031066) (Abnormal ovarian physiology) 62.50%
- [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) and [HP:0012872](http://purl.obolibrary.org/obo/HP_0012872) (Abnormal vas deferens morphology) 62.50%
- [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) and [HP:0010790](http://purl.obolibrary.org/obo/HP_0010790) (Hyoplasia of the Leydig cells) 62.50%
- [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) and [HP:0010789](http://purl.obolibrary.org/obo/HP_0010789) (Abnormality of the Leydig cells) 62.50%
- [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) and [HP:0010311](http://purl.obolibrary.org/obo/HP_0010311) (Aplasia/Hypoplasia of the breasts) 62.50%
- [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) and [HP:0008684](http://purl.obolibrary.org/obo/HP_0008684) (Aplasia/hypoplasia of the uterus) 62.50%
- [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) and [HP:0000869](http://purl.obolibrary.org/obo/HP_0000869) (Secondary amenorrhea) 62.50%
- [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) and [HP:0000151](http://purl.obolibrary.org/obo/HP_0000151) (Aplasia of the uterus) 62.50%
- [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) and [HP:0000134](http://purl.obolibrary.org/obo/HP_0000134) (Female hypogonadism) 62.50%
- [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) and [HP:0000130](http://purl.obolibrary.org/obo/HP_0000130) (Abnormality of the uterus) 62.50%
- [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) and [HP:0000037](http://purl.obolibrary.org/obo/HP_0000037) (Male pseudohermaphroditism) 62.50%
- [HP:0000026](http://purl.obolibrary.org/obo/HP_0000026) (Male hypogonadism) and [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) 62.50%
- [HP:0000022](http://purl.obolibrary.org/obo/HP_0000022) (Abnormality of male internal genitalia) and [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) 62.50%
- [HP:0000030](http://purl.obolibrary.org/obo/HP_0000030) (Testicular gonadoblastoma) and [HP:0100627](http://purl.obolibrary.org/obo/HP_0100627) (Displacement of the external urethral meatus) and [HP:0100783](http://purl.obolibrary.org/obo/HP_0100783) (Breast aplasia) 62.50%


